Box score
Axoft, Inc.
Reported $34.2M sold in a new Form D filed May 7, 2026 (Cambridge, Massachusetts).
- Biggest raise
- $34.2M filed May 7, 2026
- League
- Bio & Health Biotechnology
- Based in
- Cambridge, Massachusetts
- Season rank
- #75 of 1,121 in the Bio & Health League; #659 of 10,745 overall (2026)
- Incorporated
- 2021
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-05-07 | New notice | $34.2M | $34.2M | SEC |
| 2024-03-05 | New notice not ranked | $8.8M | $9.3M | SEC |
| 2024-03-05 | New notice | $500K | $5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2014351.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Memento Medicines, Inc. rookie | Bio & Health | $38M |
| 2 | Caldera Therapeutics, Inc. rookie | Bio & Health | $37.5M |
| 3 | Consano Bio, Inc. | Bio & Health | $34.8M |
| 4 | NextPoint Therapeutics, Inc. | Bio & Health | $33.7M |
| 5 | Alloy Therapeutics, Inc. | Bio & Health | $30M |
| 6 | Dash Bio, Inc. | Bio & Health | $30M |